Volume 35, Issue 9 (12-2024)
Studies in Medical Sciences 2024, 35(9): 746-755 |
Back to browse issues page
Ethics code: IR.IAU.KERMAN.REC.1402.013
Clinical trials code: IR.IAU.KERMAN.REC.1402.013
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Pourkhorasani A, Khandan Dezfuli N, forghani M, Stabraghi E, Amini K. THE EFFECT OF NATIVE PROBIOTICS ON THE EXPRESSION OF BAX/ BCL2 ANTICANCER GENES IN HT-29 CANCER CELLS BY REAL TIME PCR METHOD. Studies in Medical Sciences 2024; 35 (9) :746-755
URL: http://umj.umsu.ac.ir/article-1-6360-en.html
URL: http://umj.umsu.ac.ir/article-1-6360-en.html
Department of Microbiology, Sirjan Branch, Islamic Azad University, Sirjan, Iran (Corresponding Author) , nooshinkhandan22@gmail.com
Abstract: (412 Views)
Background & Aims: Colorectal cancer is one of the most common malignant tumors in humans. Probiotics affect the balance of beneficial and harmful bacteria in the intestine, shifting this balance in favor of increasing the population of beneficial bacteria and providing health benefits. Therefore, the aim of the present study is to investigate the effect of indigenous probiotics on the expression of anti-cancer genes Bax and Bcl-2 in HT-29 cancer cells using the real-time PCR method.
Materials & Methods: In this study, after culturing HT-29 cancer cells and treating them with probiotic extract, RNA extraction and cDNA synthesis were performed. Real-time PCR was performed using primers specific to the anti-cancer genes Bax and Bcl-2 in a Corbett device. The MTT assay was also performed to investigate the toxicity of the native probiotic extract.
Results: The MTT assay showed that increasing the concentration of the studied extract caused a dose-dependent decrease in cell viability. The IC50 value for the probiotic extract was calculated to be 300 µg/mL. Additionally, the expression levels of Bax and Bcl-2 genes in cells treated with Lactococcus rhamnosus cell-free supernatant were 1.344 and 1.447, respectively, indicating an increase in the expression of these two genes. (The expression level of the Bax gene increased by 1.344-fold, and the expression level of the Bcl-2 gene increased by 1.447-fold in the treatment group compared to the control group (p < 0.05). It is necessary to mention the p-value.)
Discussion: Considering the low toxicity of the probiotic extract in the MTT assay and the increase in the expression of Bax and Bcl-2 genes, it seems that probiotics can be used as therapeutic supplements in the prevention and treatment of gastrointestinal cancers. These findings indicate that indigenous probiotics can be used as a novel therapeutic strategy with high efficacy and low side effects for the treatment and prevention of colon cancer.
Materials & Methods: In this study, after culturing HT-29 cancer cells and treating them with probiotic extract, RNA extraction and cDNA synthesis were performed. Real-time PCR was performed using primers specific to the anti-cancer genes Bax and Bcl-2 in a Corbett device. The MTT assay was also performed to investigate the toxicity of the native probiotic extract.
Results: The MTT assay showed that increasing the concentration of the studied extract caused a dose-dependent decrease in cell viability. The IC50 value for the probiotic extract was calculated to be 300 µg/mL. Additionally, the expression levels of Bax and Bcl-2 genes in cells treated with Lactococcus rhamnosus cell-free supernatant were 1.344 and 1.447, respectively, indicating an increase in the expression of these two genes. (The expression level of the Bax gene increased by 1.344-fold, and the expression level of the Bcl-2 gene increased by 1.447-fold in the treatment group compared to the control group (p < 0.05). It is necessary to mention the p-value.)
Discussion: Considering the low toxicity of the probiotic extract in the MTT assay and the increase in the expression of Bax and Bcl-2 genes, it seems that probiotics can be used as therapeutic supplements in the prevention and treatment of gastrointestinal cancers. These findings indicate that indigenous probiotics can be used as a novel therapeutic strategy with high efficacy and low side effects for the treatment and prevention of colon cancer.
Type of Study: Research |
Subject:
میکروبیولوژی
References
1. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinog 2010;31(1):100-10. [DOI:10.1093/carcin/bgp263]
2. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterol Review/ Prz Gastroenterol 2019;14(2):89-103. [DOI:10.5114/pg.2018.81072]
3. Cheng Y, Ling Z, Li L. The intestinal microbiota and colorectal cancer. Front Immunol 2020;11:615056. [DOI:10.3389/fimmu.2020.615056]
4. Śliżewska K, Markowiak-Kopeć P, Śliżewska W. The role of probiotics in cancer prevention. Cancers 2020;13(1):20. [DOI:10.3390/cancers13010020]
5. Peña‐Blanco A, García‐Sáez AJ. Bax, Bak and beyond-mitochondrial performance in apoptosis. The FEBS J 2018;285(3):416-31. [DOI:10.1111/febs.14186]
6. Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N. [Retracted] Apoptosis and Molecular Targeting Therapy in Cancer. BioMed Res Int 2014;2014(1):150845. [DOI:10.1155/2014/150845]
7. Ghasemi A, Khanzadeh T, Heydarabad MZ, Khorrami A, Esfahlan AJ, Ghavipanjeh S, et al. Evaluation of BAX and BCL-2 gene expression and apoptosis induction in acute lymphoblastic leukemia cell line CCRF-CEM after high-dose prednisolone treatment. Asian Pacific journal of cancer prevention: APJCP 2018;19(8):2319. [PMID: 30141309] [PMCID: PMC6171400]
8. Rebersek M. Gut microbiome and its role in colorectal cancer. BMC cancer 2021;21(1):1325. [DOI:10.1186/s12885-021-09054-2]
9. Davoodvandi A, Fallahi F, Tamtaji OR, Tajiknia V, Banikazemi Z, Fathizadeh H, et al. An update on the effects of probiotics on gastrointestinal cancers. Front Pharmacol 2021;12:680400. [DOI:10.3389/fphar.2021.668567]
10. Ding S, Hu C, Fang J, Liu G. The protective role of probiotics against colorectal cancer. Oxidative J Mol Cell Med 2020;2020(1):8884583. [DOI:10.1155/2020/8884583]
11. Fong W, Li Q, Yu J. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncog 2020;39(26):4925-43. [DOI:10.1038/s41388-020-1341-1]
12. Chen Z-Y, Hsieh Y-M, Huang C-C, Tsai C-C. Inhibitory effects of probiotic Lactobacillus on the growth of human colonic carcinoma cell line HT-29. Mol 2017;22(1):107. [DOI:10.3390/molecules22010107]
13. Askari N, Shafieipour S, Aghajanpour M. Role of BAX, BCL-2, and MICAL-2 genes in esophageal cancer. Res Med 2019;43:170-6. [google scholar]
14. Udommethaporn S, Tencomnao T, McGowan EM, Boonyaratanakornkit V. Assessment of anti-TNF-α activities in keratinocytes expressing inducible TNF-α: a novel tool for anti-TNF-α drug screening. PLoS One 2016;11(7):e0159151. [DOI:10.1371/journal.pone.0159151]
15. ECDC. Surveillance of antimicrobial resistance in Europe-annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. European Centre for Disease Prevention and Control Stockholm, Sweden; 2018. [URL:]
16. Wang Z, Li L, Wang S, Wei J, Qu L, Pan L, et al. The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy. Front Pharmacol 2022;13:1025860. [DOI:10.3389/fphar.2022.1025860]
17. Bedada TL, Feto TK, Awoke KS, Garedew AD, Yifat FT, Birri DJ. Probiotics for cancer alternative prevention and treatment. Biomed Pharmacother 2020;129:110409. [DOI:10.1016/j.biopha.2020.110409]
18. Ahmadizadeh C. The study of expression of PTEN and AKT1 genes in co-culturing of HT29 colon cancer cell line with Streptococcus thermophilus. Feyz Med Sci J 2018;22(6):624-31. [google scholar]
19. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr 2011;6(3):261-74. [DOI:10.1007/s12263-011-0218-x]
20. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002;277(52):50959-65. [DOI:10.1074/jbc.M207050200]
21. Jahani-Sherafat S, Azimirad M, Ghasemian-Safaei H, Amoli HA, Moghim S, Sherkat G, et al. The effect of intestinal microbiota metabolites on HT29 cell line using MTT method in patients with colorectal cancer. Gastroenterol Hepatol from Bed to Bench 2019;12(Suppl1):S74. [PMID: 32099605] [PMCID: PMC7011068]
22. ZibasazTalebi A, Ahmadizadh C. The Study of Expression of Casp3/Bax Genes in HT29 Colon Cancer Cell Line with Lactobacillus rhamnosus Co-Culturing. J Ilam Univ Med Sci 2020;28(4):25-35. [DOI:10.29252/sjimu.28.4.25]
23. Adeli H, Ahmadizadeh C, Sadeghi Zali MH. Investigation of the Effect of Lactobacillus Brevis Bacteria on the Expression of Rel A, IKB, and Casp3 Genes in HT29 Colon Cancer Cells. Intern Med Today 2022;28(3):330-53. [DOI:10.32598/hms.28.3.3277.3]
24. Sayadi, Mehran, Tajik. Evaluation of the efficacy of probiotic bacterium Lactobacillus acidophilus in detoxifying aflatoxin B1 based on a simulated model of gastrointestinal secretions. Journal of Medical Sciences Studies 2018;29(4):270-81. [google scholar]
25. Taheri H, Yazdi, Mahdavi, Shekhargazar, Bayat, Mansour, et al. Evaluation of the protective effect of administration of Lactobacillus acidophilus and Lactobacillus casei in reducing the severity of infection caused by Candida albicans in BALB/c mouse model. Journal of Medical Sciences Studies 2013;23(7):784-91. [google scholar]
26. Bash A, Baran, Pakdel A, Hassan M, Zuhair, Zare, et al. Studying the effect of Lactobacillus rhamnosus (LMG 18243) administration on the growth of breast cancer in inbred BALB/c mice. Journal of Medical Sciences Studies 2011;22(3):230-8. [google scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
